21Mar 2022
The effect of Intravenous ferric‐carboxymaltose on right ventricular function – insights from the IRON‐CRT trial

The effect of Intravenous ferric‐carboxymaltose on right ventricular function – insights from the IRON‐CRT trial

Ferric carboxymaltose (FCM) improves left ventricular (LV) function in heart failure with reduced ejection fraction (HFrEF). Yet, the effect of FCM on right ventricular (RV) function remains insufficiently elucidated. Treatment with FCM in HFrEF patients improves RV function and structure and improves the RV‐contractile reserve.

  • #cardiology

Like

Save

Share